Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Opexa Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Opexa Therapeutics (United States) is a research organisation in The Woodlands, US. OpenAlex records 454 works and 24,445 citations for it. 191 researchers list it as their most recent affiliation.

454
Works
24,445
Citations
191
Researchers
49.5
Avg h-index

How has Opexa Therapeutics (United States)'s publication output changed over time?

ScholarIQpublication output · 1991–2023

Output grew0% over the shown period — from 1 works in 1991 to 1 in 2023.

1
1
2
1
1
3
2
1
19912013201520162018201920202023

Who are the most-cited researchers behind Opexa Therapeutics (United States)?

ScholarIQtop researchers by citations
1
Antonio González-Martı́n · Ovarian cancer diagnosis and treatment
658 works34,977 citations

What are the most-cited papers on Opexa Therapeutics (United States)?

ScholarIQmost cited works
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Susana Banerjee, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, Elizabeth Lowe, Ralph Bloomfield, Paul DiSilvestro
New England Journal of Medicine. 20182,881 CitationsOPEN ACCESS
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A. Ledermann, Domenica Lorusso, Ignace Vergote, Noa Ben-Baruch, Christian Marth, Radosław Mądry, René dePont Christensen, Jonathan S. Berek, Anne Dørum, Anna V. Tinker, Andreas du Bois, Antonio González-Martı́n, Philippe Follana, Benedict B. Benigno, Per Rosenberg, Lucy Gilbert, B.J. Rimel, Joseph Buscema, John Balser, Shefali Agarwal, Ursula A. Matulonis
New England Journal of Medicine. 20162,477 CitationsOPEN ACCESS
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney A. Spannuth Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, К. Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley Haggerty, María Jesús Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk
New England Journal of Medicine. 20192,291 CitationsOPEN ACCESS
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martı́n, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédèric Selle, Jalid Sehouli, Domenica Lorusso, Eva María Guerra Alia, Alexander Reinthaller, Shoji Nagao, Claudia Lefeuvre‐Plesse, Ulrich Canzler, Giovanni Scambia, Alain Lortholary, Frederik Marmé, Pierre Combe, Nikolaus de Gregorio, Manuel Rodrigues, Paul Buderath, Coraline Dubot, Alexander Burges, Benoît You, Éric Pujade-Lauraine, Philipp Harter
New England Journal of Medicine. 20192,070 CitationsOPEN ACCESS
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan A. Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti, Christina Fotopoulou, Antonio González-Martı́n, Sigurd Lax, Domenica Lorusso, Christian Marth, Philippe Morice, Remi A. Nout, D. O’Donnell, Denis Querleu, Maria Rosaria Raspollini, Jalid Sehouli, Alina Sturdza, Alexandra Taylor, Anneke M. Westermann, Pauline Wimberger, Nicoletta Colombo, François Planchamp, Carien L. Creutzberg
International Journal of Gynecological Cancer. 20201,972 CitationsOPEN ACCESS

How much of the research on Opexa Therapeutics (United States) is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
8%
Bronze
75%
Closed
17%

Related on ScholarIQ

Seismic Imaging and Inversion Techniques
Top Topic
Hydraulic Fracturing and Reservoir Analysis
Top Topic
Virus-based gene therapy research
Top Topic
Hydrocarbon exploration and reservoir analysis
Top Topic
Reservoir Engineering and Simulation Methods
Top Topic
RNA Interference and Gene Delivery
Top Topic
470M+ articles · free account